C93.3: Juvenile myelomonocytic leukaemia
Juvenile myelomonocytic leukaemia (JMML) is a rare form of blood cancer found in young children, typically under the age of four. It's characterised by the overproduction of immature white blood cells, known as myelomonocytes, in the bone marrow. This abnormal growth interferes with the body's ability to produce healthy blood cells and can affect other organ systems, like the liver, spleen, and skin. Initial symptoms can include fatigue, weakness, pallor, recurring fever, and unexplained weight loss. The condition may also cause increased susceptibility to infections, as well as easy bruising or bleeding due to a lowered count of healthy platelets in the blood. The disease often progresses rapidly, emphasizing the importance of early detection and intervention. The exact cause of JMML remains unknown, however, certain genetic mutations have been identified in relation to the condition.
Patient Disclaimer
The information provided on this page is for general educational purposes only. It is not intended for self-diagnosis and does not replace professional medical advice. Always consult your doctor or a qualified healthcare provider with any questions or concerns about your health.
If you see an ICD diagnosis code (e.g., on a medical report), be aware that doctors may also include additional indicators to express diagnostic certainty. Only a healthcare professional can interpret these codes accurately in the context of your individual case.
For a complete understanding of your condition and what the diagnosis means for you, please speak directly with your doctor.